WallStSmart
PACB

Pacific Biosciences of California

NASDAQ: PACB · HEALTHCARE · MEDICAL DEVICES

$1.59
+8.16% today

Updated 2026-04-30

Market cap
$493.67M
P/E ratio
P/S ratio
3.09x
EPS (TTM)
$-1.82
Dividend yield
52W range
$1 – $3
Volume
5.8M

Pacific Biosciences of California (PACB) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item2007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-16.73M$-38.30M$-74.84M$-122.00M$-102.97M$-76.82M$-29.83M$-51.47M$-47.89M$-67.93M$-67.52M$-66.43M$-78.31M$19.50M$-111.18M$-263.21M$-266.55M$-206.06M$-111.21M
Capital expenditures$3.05M$5.70M$5.18M$5.26M$9.28M$1.70M$909000.00$1.61M$3.01M$8.21M$10.43M$1.85M$2.84M$1.04M$5.93M$16.93M$8.84M$6.19M$2.71M
Depreciation
Stock-based comp$1.66M$2.13M$3.63M$9.69M$12.38M$9.71M$9.90M$9.94M$13.84M$19.56M$20.35M$23.15M$16.40M$17.53M$80.73M$78.61M$72.12M$71.04M$41.67M
Free cash flow$-19.78M$-44.01M$-80.02M$-127.25M$-112.26M$-78.53M$-30.74M$-53.08M$-50.90M$-76.14M$-77.95M$-68.28M$-81.15M$18.46M$-117.11M$-280.14M$-275.39M$-212.25M$-113.92M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$-88.78M$-12.32M$-20.18M$10.09M$-2.82M$-16.86M$-258000.00$2.34M$10.28M$52.02M$379.87M